Covalon Technologies, a firm based in Mississauga, Ontario, Canada, landed FDA clearance for its SilverCoat Silicone Foley Catheter. The catheter is made entirely of silicone and coated with a lubricious material embedded with silver ions. The combination keeps the catheter slick for comfortable insertion and removal while preventing pathogens from making home on its surface.
Some details according to Covalon:
The silver is retained in the hydrophilic coating through ionic bonding and is covalently bonded to the silicone surface through Covalon’s patented surface modification technology. The SilverCoat coating on the silicone Foley catheter provides a zone of inhibition to bacteria around the catheter surface and resists microbial colonization on the surface of the device thereby reducing the likelihood of catheter-related urinary tract infections.
“Obtaining FDA clearance on our new SilverCoat Foley catheter opens the United States market for Covalon to license and sell our catheters.” said Brian Pedlar, Covalon’s CEO. “We believe our patented technology that is incorporated into our SilverCoat Foley provides superior protection for patients at risk of developing a CAUTI. With up to 25% of the patients hospitalized in the United States catheterized and annually over 500,000 patients with indwelling catheters developing an infection, we believe the opportunity for Covalon’s SilverCoat Foley to make a strong clinical impact is compelling.”
Product page: SilverCoat Antimicrobial Silicone Foley Catheter…
Source: Covalon…